Search

Your search keyword '"Burnichon, Nelly"' showing total 302 results

Search Constraints

Start Over You searched for: Author "Burnichon, Nelly" Remove constraint Author: "Burnichon, Nelly"
302 results on '"Burnichon, Nelly"'

Search Results

3. MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paraganglioma

7. International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers

10. EPAS1‐mutated paragangliomas associated with haemoglobin disorders

11. Update of the UMD-VHL database: classification of 164 challenging variants based on genotype–phenotype correlation among 605 entries

13. Update of the UMD-VHL database: classification of 164 challenging variants based on genotype-phenotype correlation among 605 entries.

14. Identification of a new VHL exon and complex splicing alterations in familial erythrocytosis or von Hippel-Lindau disease

16. Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations

17. Diversity of genetic events associated with MLH1 promoter methylation in Lynch syndrome families with heritable constitutional epimutation

18. Data from Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma

19. Supplementary data from In Vivo Detection of Succinate by Magnetic Resonance Spectroscopy as a Hallmark of SDHx Mutations in Paraganglioma

20. Data from Germline Mutations in the Mitochondrial 2-Oxoglutarate/Malate Carrier SLC25A11 Gene Confer a Predisposition to Metastatic Paragangliomas

21. Supplementary Figures 1 - 3 from MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma

22. Supplementary Data from Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma

23. Table S4 from Germline Mutations in the Mitochondrial 2-Oxoglutarate/Malate Carrier SLC25A11 Gene Confer a Predisposition to Metastatic Paragangliomas

24. supplementary file data from Germline Mutations in the Mitochondrial 2-Oxoglutarate/Malate Carrier SLC25A11 Gene Confer a Predisposition to Metastatic Paragangliomas

25. SDHx mutation and pituitary adenoma: can in vivo 1H-MR spectroscopy unravel the link?

26. Comprehensive in silico and functional studies for classification of EPAS1/HIF2A genetic variants identified in patients with erythrocytosis

27. In silico and Functional Studies for Classification of EPAS1/HIF2A Genetic Variants Identified in Patients with Erythrocytosis

28. Consensus on molecular imaging and theranostics in neuroendocrine neoplasms

29. Long‐Term Outcomes in Head and Neck Paragangliomas Managed with Intensity‐Modulated Radiotherapy

30. SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma

31. International initiative for a curated SDHB variant database improving the diagnosis of hereditary paraganglioma and pheochromocytoma

34. Long‐Term Outcomes in Head and Neck Paragangliomas Managed with Intensity‐Modulated Radiotherapy.

35. Novel germline MET pathogenic variants in French patients with papillary renal cell carcinomas type I

36. Quantifying evidence toward pathogenicity for rare phenotypes: The case of succinate dehydrogenase genes, SDHB and SDHD

37. Genetic spectrum in a Canadian cohort of apparently sporadic pheochromocytomas and paragangliomas: New data on multigene panel retesting over time

38. Genetic Spectrum in a Canadian Cohort of Apparently Sporadic Pheochromocytomas and Paragangliomas (PPGLs): New Data on Multigene Panel Retesting Over Time

39. International initiative for a curated SDHB variant database improving the diagnosis of hereditary paraganglioma and pheochromocytoma

40. Germline MET pathogenic variants in papillary renal cell carcinomas type I: specific phenotype in French population and novel germline pathogenic variant MET c.3389T>C, p.(Leu1130Ser)

42. Overexpression of miR‐483‐5p is confined to metastases and linked to high circulating levels in patients with metastatic pheochromocytoma/paraganglioma

45. Genetic spectrum in a Canadian cohort of apparently sporadic pheochromocytomas and paragangliomas: New data on multigene panel retesting over time.

46. Quantitative evidence evaluation for singleton rare missense variants in rare distinctive adult-onset phenotypes: the exemplar of SDHB and SDHD

47. Sino-European Differences in the Genetic Landscape and Clinical Presentation of Pheochromocytoma and Paraganglioma

48. Screening of a Large Cohort of Asymptomatic SDHx Mutation Carriers in Routine Practice

Catalog

Books, media, physical & digital resources